CCL3 and malaria: The meta-analysis using the fixed-effects model demonstrated similar findings to the random effects model, showing a significant elevation in MIP-1α malaria cases compared to uninfected participants (p < 0.001, SMD: 1.5424, 95% CI: 1.3359 to 1.7488, Figure 3).